Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • danwiththeplan
    Member
    • Sep 2011
    • 72

    #1

    Two related transcriptomes: merging but avoiding fake fusion transcripts

    Hi. I'd like to discuss a situation that has been partially discussed in this thread:

    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc


    I have RNAseq data from two cultivars of a plant which is polyploid. I've taken the approach of doing a de novo transcriptome assembly separately for each cultivar.

    Examining the transcriptomes reveals that about 1/3 of the transcripts are unique to a cultivar, and 2/3 of the transcripts have a very close or identical BLAST hit in the other transcriptome.. but these hits are rarely full-length. There are actually few transcripts with a 100% full-length match in the other cultivar/genotype.

    Doing differential expression analysis for different conditions in the same cultivar, no problem, I can do that with standard approaches. However, I'm not entirely sure how to do differential expression analyses across cultivars/genotype.

    I know that I somehow need to produce a "combined" reference transcriptome, by one of two approaches:

    (1) Simply throw all RNAseq reads from both cultivars into a new de novo assembly (which I'm doing now)

    (2) Combine the two existing de novo assemblies into a new assembly using an OLC-based method like CAP3 or MIRA

    To me, the main thing to avoid is assemblies containing "fake" transcripts that are half from one cultivar and half from another, and I can see approach (1) doing that a lot, because the de novo assembly breaks everything into kmers and you lose information about which full-length transcripts come from which cultivar/genotype. I am thinking that approach (2) is better for avoiding "fake" fusion transcripts since it starts from the point of long transcripts that are known to come from just one cultivar/genotype.

    PS. Did I mention it's a horrible polyploid and there's no genome?

    Does anyone have an opinion or similar experience?
  • dongilbert
    Junior Member
    • Jun 2012
    • 9

    #2
    You don't say how you did your single cultivar assemblies that were short, but if it was Trinity, then add Velvet/Oases and SoapTrans and/or TransAbyss, all of which give you more complete assemblies if your input is paired end reads. Use multi-kmers up to size of reads, as that gives more complete assembly of the high expressed genes.

    See here for software that picks your best gene subset of several transcript assemblies of the same data:

    see about/EvidentialGene_trassembly_pipe.html for the software.

    This paper is an independently done comparison of methods, with essentially same conclusions, that combining best of several assembliers, using CDS-size metrics, gives you the most complete genes:


    The artifact gene-joins (fake fusions) are exacerbated using post-assembly mergers such as CAP and velvet/o -merge (maybe also mira, i've not tested that tho). In general the post-assembly mergers don't use all the read pair info and make more mistakes by joining things that don't belong.

    You can use your cultivar mixed read set for another assembly, if above re-assembly with other assemblers doesn't help enough. The CDS-selection pipeline I've built throws out those mistakes as the CDS never spans gene joins (too many stop codons).

    There are several tips here that work to improve mRNA assemblies


    For matching your 2 cultivars I suggest matching CDS also/instead as much of the assembly differences (artifacts, shortness) will be in UTRs. You may also want to measure expression differences only on CDS (or CDS +100bp)
    to avoid those assembly artifacts.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Working...